CAMP and infection: Of note, previous reports have identified various CAMPs in synovial fluid, including the cathelicidin LL-37, β defensins, and dermcidin, although the expression levels of the peptides vary depending on the disease type (rheumatoid/osteoarthritis) and infection status (25, 27, 28).